Oliver Dorigo

2.0k total citations · 1 hit paper
13 papers, 1.5k citations indexed

About

Oliver Dorigo is a scholar working on Oncology, Immunology and Genetics. According to data from OpenAlex, Oliver Dorigo has authored 13 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Immunology and 5 papers in Genetics. Recurrent topics in Oliver Dorigo's work include Virus-based gene therapy research (5 papers), Cancer Research and Treatments (4 papers) and Immunotherapy and Immune Responses (4 papers). Oliver Dorigo is often cited by papers focused on Virus-based gene therapy research (5 papers), Cancer Research and Treatments (4 papers) and Immunotherapy and Immune Responses (4 papers). Oliver Dorigo collaborates with scholars based in United States, France and Netherlands. Oliver Dorigo's co-authors include Venkatesh Krishnan, Mark Kowarsky, Rachel Brewer, Amira Barkal, Irving L. Weissman, Balyn W. Zaro, Jason Hatakeyama, Maxim Markovic, Layla J. Barkal and Robert E. Sobol and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and The Journal of Immunology.

In The Last Decade

Oliver Dorigo

13 papers receiving 1.4k citations

Hit Papers

CD24 signalling through m... 2019 2026 2021 2023 2019 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oliver Dorigo United States 10 888 612 561 149 105 13 1.5k
Jason Hatakeyama United States 13 702 0.8× 678 1.1× 390 0.7× 176 1.2× 40 0.4× 17 1.3k
Eleni Maniati United Kingdom 19 708 0.8× 580 0.9× 750 1.3× 272 1.8× 58 0.6× 40 1.6k
Monther Al‐Alwan Saudi Arabia 22 840 0.9× 626 1.0× 823 1.5× 217 1.5× 42 0.4× 46 1.8k
Erika Zonari Italy 9 700 0.8× 886 1.4× 534 1.0× 344 2.3× 42 0.4× 14 1.5k
Keiji Furuuchi Japan 21 660 0.7× 840 1.4× 536 1.0× 240 1.6× 62 0.6× 48 1.8k
Paul R. Gielen Netherlands 9 741 0.8× 455 0.7× 501 0.9× 115 0.8× 39 0.4× 11 1.2k
McLane J. Watson United States 8 791 0.9× 489 0.8× 561 1.0× 439 2.9× 64 0.6× 10 1.4k
Linda N. Liu United States 12 672 0.8× 609 1.0× 747 1.3× 156 1.0× 62 0.6× 20 1.4k
Miriam R. Fein United States 5 769 0.9× 336 0.5× 492 0.9× 144 1.0× 54 0.5× 8 1.2k
Minu K. Srivastava United States 18 1.3k 1.5× 480 0.8× 960 1.7× 209 1.4× 53 0.5× 52 2.0k

Countries citing papers authored by Oliver Dorigo

Since Specialization
Citations

This map shows the geographic impact of Oliver Dorigo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Dorigo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Dorigo more than expected).

Fields of papers citing papers by Oliver Dorigo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Dorigo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Dorigo. The network helps show where Oliver Dorigo may publish in the future.

Co-authorship network of co-authors of Oliver Dorigo

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Dorigo. A scholar is included among the top collaborators of Oliver Dorigo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Dorigo. Oliver Dorigo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Levinson, Kimberly, Oliver Dorigo, Krista M. Rubin, & Kathleen N. Moore. (2019). Immunotherapy in Gynecologic Cancers: What We Know Now and Where We Are Headed. American Society of Clinical Oncology Educational Book. 39(39). e126–e140. 31 indexed citations
2.
Barkal, Amira, Rachel Brewer, Maxim Markovic, et al.. (2019). CD24 signalling through macrophage Siglec-10 is a target for cancer immunotherapy. Nature. 572(7769). 392–396. 956 indexed citations breakdown →
3.
Gill, Navjot Kaur, Kendra D. Nyberg, Linus Lee, et al.. (2018). A scalable filtration method for high throughput screening based on cell deformability. Lab on a Chip. 19(2). 343–357. 19 indexed citations
4.
Krishnan, Venkatesh, et al.. (2018). Tumor associated macrophages in gynecologic cancers. Gynecologic Oncology. 149(1). 205–213. 68 indexed citations
5.
He, Huanhuan, Masamitsu Kanada, Bruce T. Schaar, et al.. (2017). Imaging of Tumor-Associated Macrophages in a Transgenic Mouse Model of Orthotopic Ovarian Cancer. Molecular Imaging and Biology. 19(5). 694–702. 13 indexed citations
7.
Horton, Holly M., et al.. (1999). IL-2 Plasmid Therapy of Murine Ovarian Carcinoma Inhibits the Growth of Tumor Ascites and Alters Its Cytokine Profile. The Journal of Immunology. 163(12). 6378–6385. 23 indexed citations
8.
Dorigo, Oliver, et al.. (1998). Sensitization of rat glioblastoma multiforme to cisplatin in vivo following restoration of wild-type p53 function. Journal of neurosurgery. 88(3). 535–540. 39 indexed citations
9.
Fakhrai, Habib, Daniel L. Shawler, Charles Van Beveren, et al.. (1997). Construction and Characterization of Retroviral Vectors for Interleukin-2 Gene Therapy. Journal of Immunotherapy. 20(6). 437–448. 7 indexed citations
10.
Fakhrai, Habib, Oliver Dorigo, Daniel L. Shawler, et al.. (1996). Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy.. Proceedings of the National Academy of Sciences. 93(7). 2909–2914. 264 indexed citations
11.
Shawler, Daniel L., Oliver Dorigo, Ruth A. Gjerset, et al.. (1995). Comparison of Gene Therapy with Interleukin-2 Gene Modified Fibroblasts and Tumor Cells in the Murine CT-26 Model of Colorectal Carcinoma. Journal of Immunotherapy. 17(4). 201–208. 20 indexed citations
12.
Gjerset, Ruth A., Habib Fakhrai, Daniel L. Shawler, et al.. (1995). Characterization of a new human glioblastoma cell line that expresses mutant P53 and lacks activation of the PDGF pathway. In Vitro Cellular & Developmental Biology - Animal. 31(3). 207–214. 9 indexed citations
13.
Herndier, Brian, Michael McGrath, Nancy W. Abbey, et al.. (1993). A Non-Lymphoma Idiotype Is Indicative and Predictive for B Cell Malignancies in AIDS. Hybridoma. 12(5). 529–537. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026